fbpx
eBook

Investing in the Cannabis Industry? Read about the medicinal applications of cannabis in this chapter.

Medical History

Cannabis has an extremely long history with the first documented case of its use dating back to the time of Chinese Emperor Shen Nung, known as the “father of Chinese medicine” Circa 2800 BC. The benefit of cannabis use has also been mentioned in ancient texts of the Greeks, Romans, Indian Hindus and Assyrians. Ancient Hindu texts attribute the onset of fever with the ‘hot breath of the gods’ who were angered by the afflicted person’s behaviour. Using cannabis in religious rites appeased the gods and hence reduced the fever.

Recent scientific evidence provides an alternative explanation of course – THC acts on the hypothalamus to reduce body temperature.

In the 19th Century, marijuana emerged as mainstream medicine in the West. Studies in the 1840s by a French psychiatrist by the name of Jacques-Joseph Moreau found that marijuana suppressed headaches increased appetites, and aided people to sleep.

By 1850, marijuana had made its way into the United States Pharmacopeia [an official public standards-setting authority for all prescription and over-the-counter medicines], which listed marijuana as a treatment for numerous afflictions.

 

_________________________

This is an excerpt from the book ‘The Ultimate Guide To Investing In Cannabis‘ by Investment Advisor Jacob Coombs.

Click here to download the FREE eBook

eBook

 

Disclaimer: Capital 19 Pty Ltd ABN 17 124 264 366 AFSL 441891 (‘Capital 19’) believes the information contained is reliable, however, no warranty is given as to its accuracy and persons relying on this information do so at their own risk. This communication is for general information only and was prepared for multiple distributions and does not take account of the specific investment objectives of individual recipients and it may not be appropriate in all circumstances. Persons relying on this information should do so considering their specific investment objectives and financial situations. Any person considering action based on this communication must seek individual advice relevant to their circumstances and investment objectives. Subject to any liability which cannot be excluded under the relevant laws. Any opinions or forecasts reflect the judgment and assumptions of Capital 19 and its representatives based on information at the date of publication and may later change without notice. Any projections contained in this presentation are estimates only and may not be realised in the future. The investment manager certifies that all the views expressed in this document accurately reflect their views about the companies and securities referred to in this document and that their remuneration is not directly or indirectly related to the views. Capital 19, its directors, representatives, employees or related parties may have an interest in any of the companies and securities in this document and may earn revenue from the sale or purchase of any financial product referred to in this document or any advice. Past performance is not a reliable indicator of future performance. Unauthorised use, copying, distribution, replication, posting, transmitting, publication, display, or reproduction in whole or in part of the information contained in this document is prohibited without obtaining prior written permission from Capital 19.